22nd Annual Wharton Health Care Business Conference

Speakers and Panels: MBA “Shark Tank” Competition

Do you have what it takes to stand before an audience of 500 and pitch your next big idea? How about before a panel of seasoned investors who will quiz you on the validity of your venture? The first-ever WHCBC Shark Tank Competition aims to connect current Wharton students pursuing entrepreneurial ventures in healthcare with ex-CEOs and investors with a successful track record of identifying profitable healthcare opportunities.

1:10 PM – 2:10 PM (Meade Room)


Sharks:

Adele Oliva - Co-Founder and Partner, 1315 Capital
Adele Oliva

Adele Oliva

Co-Founder and Partner, 1315 Capital

Adele Oliva brings over 25 years of finance and healthcare experience to 1315 Capital, including 18 years in private equity. Throughout her investing career, she has focused on commercial stage specialty pharmaceutical, medical technology and healthcare service investments.

Ms. Oliva co-founded 1315 Capital in 2014 to establish a firm focused on healthcare growth investing. She was recruited to Quaker Partners, which she joined in 2007, to expand their growth and expansion stage investing practice. Prior to Quaker, Ms. Oliva was Co-Head of US Healthcare at Apax Partners, a global private equity firm, where she started in 1997.

Forbes has recognized Ms. Oliva on its Midas List of top 100 technology investors worldwide, top 10 life science investors and top women in venture capital.

Ms. Oliva has served on the board of many high growth companies including Ascent Healthcare Solutions (acquired by Stryker), EKR Therapeutics (acquired by Cornerstone Therapeutics), ESP Pharma (acquired by Protein Design Labs), Esprit Pharma (acquired by Allergan), Precision Dermatology (acquired by Valeant), Prometheus Labs (acquired by Nestle) and SkinMedica (acquired by Allergan). She currently serves on the boards of Novasom, Onkos Surgical, TearScience and TelaBio.

Prior to entering private equity as a Kauffman Fellow in 1997, Ms. Oliva built a strong foundation in finance and healthcare at CoreStates in commercial banking and Baxter Healthcare in marketing and business development. Ms. Oliva received a BSc from St. Joseph's University and a MBA from Cornell University, where she was awarded the Albert Fried Fellowship.

Doug A. Present - Former CEO, Managed Health Care Associates; Chairman, Genoa
Doug A. Present

Doug A. Present

Former CEO, Managed Health Care Associates
Chairman, Genoa

Doug Present is a Lecturer at the Wharton School where, for the last 9 years, he has taught health care services to second year MBA students in the Health Care Management program. Doug has received the prestigious “Excellence in Teaching Award” for being a top rated Professor as voted upon by Wharton students for the last four consecutive years.

Doug has had a long and accomplished career focused on the services sector of the US health care system. He is currently an investor in, and advisor to, several middle and upper market, private-equity-backed health care services companies. He serves as Chairman of the Board of Genoa Health Care, the nation’s largest provider of on-site pharmacy services to patients with mental health disorders. Doug is also Chairman of the Board of Golden State Medical Supply, the largest supplier of generic drugs to the US Government. He is also on the Board of Cotiviti, the nation’s leading payment integrity provider to CMS and other top commercial insurance plans. He has been a Board Member and advisor to five other private-equity-backed health care services companies during his career.

From 2001 through 2013, Doug served as the CEO of Managed Health Care Associates, Inc. (MHA). MHA is the largest Group Purchasing Organization in the country focused on alternate site/non-acute settings. During Doug’s tenure, MHA’s purchasing volume with its client base grew from approximately $700 million in contracted sales to approximately $6 billion, while MHA’s earnings grew over 20 times. Under Doug’s leadership, MHA evolved beyond the traditional GPO model into a full health care services company that provides its clients with a variety of services including managed care contracting, software, data mining, claims reconciliation and legislative advocacy. In May of 2013, after being owned by a series of private equity companies, all of whom made significant returns in their investments, MHA was sold to Roper Industries (NYSE:ROP) for $1 billion in an all cash transaction.

Doug graduated with a BA from Syracuse University in 1986 and with an MBA from The Wharton School in 1990. He is on the Advisory Board of the Whitman School of Business at Syracuse University. Doug is also involved with several charitable organizations and recently served as President of the Board of Directors of Project Morry, a non-profit, year-round youth development organization anchored by a residential summer camp experience. He lives in Summit, New Jersey with his wife and two children.

Sunil Wadhwani - Managing Partner, SWAT Capital; Co-Founder, iGate Corporation
Sunil Wadhwani

Sunil Wadhwani

Managing Partner, SWAT Capital
Co-Founder, iGate Corporation

Sunil Wadhwani co-founded, and till recently was Chairman and CEO of IGATE Corporation, which provides a broad range of Information Technology services. With over 34,000 employees on four continents, IGATE has been ranked among the world’s leading consulting firms. In July 2015, IGATE was sold to Cap Gemini of France for over $4 billion. Under Sunil’s leadership as CEO, the Company was listed four times in Inc. Magazine’s ranking of the fastest-growing companies in the United States. It was also named among the “Top 100 Hot Growth” companies by Business Week and among the “Technology Fast 50” by Deloitte and Touche.

In addition to IGATE, Sunil is the Co-Founder and Chairman of the Board of Mastech Corporation, a provider of high-value information technology services and solutions. Mastech is a publicly-traded company with over 800 employees.

Sunil is an active angel investor. He has invested in over 30 early-stage technology companies and has served on the Boards of several of these ventures. These companies ae on a variety of sectors including healthcare, life sciences, software, IT services, social media and financial services.

Sunil has written articles for a variety of publications including Datamation, Systems Integrator and Reader’s Digest, and has been quoted in publications such as Business Week, the Wall Street Journal, Information Week and Investors Business Daily.

Sunil established The Wadhwani Initiative for Sustainable Healthcare (or WISH Foundation), a not-for-profit headquartered in New Delhi to support innovations in healthcare with an aim of making quality healthcare accessible to the underserved population in priority states. WISH Foundation plays a facilitative role in the healthcare ecosystem to ensure need-based, high-potential innovations and enterprises are identified, supported and scaled up to establish a sustainable healthcare innovation ecosystem.

Sunil serves or has served as a Trustee or Director of the following institutions:

  • Carnegie Mellon University
  • George Washington University
  • The U.S. Federal Reserve Bank (Pittsburgh Branch)
  • United Way Worldwide
  • UPMC Health System
  • Allegheny Conference on Community Development
  • Pittsburgh Cultural Trust

Sunil is a Distinguished Alumnus of the Indian Institute of Technology and has a Master’s degree from Carnegie-Mellon University.

Participants:

Neil Bansal - MBA Candidate, Health Care Management and Entrepreneurship, The Wharton School
Neil Bansal

Neil Bansal

MBA Candidate, Health Care Management and Entrepreneurship
The Wharton School

Neil Bansal is pursuing MBA at Wharton concentrating in Health Care Management and Entrepreneurship. Prior to Wharton, he was a private equity professional on Irving Place Capital's Health Care team. Neil was previously an investment banker in the Barclays Health Care M&A group and graduated from Indiana University with degrees in honors Economics and Finance.

Neil serves as President and CEO of Daylight, OB LLC, a medical device company developing technologies to improve health and safety in labor & delivery units. The first device currently in development is a disposable obstetrics device, called Daylight, used to elevate a baby's head to enable a safer, faster, and easier urgent cesarean section delivery. The device was invented by Dr. Rosemary Leitch, OB/GYN.

Andrew Barnell - MBA Candidate, Health Care Management, The Wharton School
Andrew Barnell

Andrew Barnell

MBA Candidate, Health Care Management
The Wharton School

In 2011, Andrew graduated from Cornell University with a B.S. in Applied Economics & Management specializing in finance.  After graduation, he joined J.P. Morgan’s healthcare investment banking group in New York, working on a variety of transactions primarily in the biotech, medical devices and life science tools sectors. After two years at J.P. Morgan, he joined Lindsay Goldberg, a middle-market private equity firm in New York focused on providing long-term growth capital to family owned businesses. Andrew is currently a first-year graduate student in the Health Care Management program at The Wharton School.

Andrew’s start-up, Geneoscopy, is developing a revolutionary screening methodology to non-invasively diagnose colorectal cancer utilizing biomarkers present in stool samples.

Anastasia D’Orazio - MBA Candidate, The Wharton School / Founder and CEO, SafeStamp
Anastasia D’Orazio

Anastasia D’Orazio

MBA Candidate, The Wharton School
Founder and CEO, SafeStamp

Anastasia D’Orazio is a 2nd year Wharton MBA student and a Founder & CEO at SafeStamp. Prior to Wharton, Anastasia specialized in launching B2B sales campaigns and performing equity research specializing in Healthcare and Technology industries at Fred Alger, a $21B fund in New York. Her previous experience includes working in the investment management at Goldman Sachs. Anastasia holds a CFA charter, B.S. in Financial Engineering, and was an awardee of the prestigious Wharton Fellowship Program.

Innovative UPenn Startup, SafeStamp, developed proprietary technology to authenticate pharmaceutical products. As 30% of medicine sold globally is counterfeit, our award-winning nanotech product, SafeStamp, works to reduce counterfeit medication in developing nations. SafeStamp gives consumers the peace of mind that comes from knowing their medicine is safe. Armed with SafeStamp, pharmaceutical manufacturers will increase profits, build brand loyalty, and protect their patients’ lives.

SafeStamp recently won a grand prize in the iDesign competition at University of Pennsylvania and attended the White House's first annual Demo Day.

Ryan Limor - MBA Candidate, Health Care Management and Entrepreneurship, The Wharton School
Ryan Limor

Ryan Limor

MBA Candidate, Health Care Management and Entrepreneurship
The Wharton School

Ryan Limor is a second-year MBA at Wharton concentrating in Health Care Management and Entrepreneurship. Prior to Wharton, he was a private equity professional at GI Partners where he focused on healthcare services & technology. Ryan was previously an investment banker in the Goldman Sachs Healthcare group and graduated from the Schreyer Honors College at the Pennsylvania State University with degrees in Finance and Economics.

Ryan is a co-founder of Armeda Health, a digital health company creating a collaborative physician network to solve complex patient cases through mobile and web-based technologies.

Wharton HCC Website

Be sure to visit the new Wharton Healthcare Club Website for the latest information on the Wharton healthcare community including upcoming events and industry speaker series lectures.

Visit HCC Website

WHCBC@Social

Connect with other conference attendees, speakers, and panelists ahead of the conference, and follow the latest updates.

Pulse Magazine

The Pulse - 2016 Edition

The Pulse is an annual publication which is distributed to all attendees of this Conference.

Download

The Wharton Health Care Conference is not just the best conference organized by students but one of the most impressive gatherings of industry leaders tackling timely and important issues in the health care industry.

Stelios Papadopoulos, Ph.D., Chairman and Founder, Exelixis

Sponsors


Bronze Sponsors

AmerisourceBergen Cigna Kindred Healthcare Regeneron

Sponsors

BDO Change Healthcare Genentech Johnson & Johnson Eli Lilly Lumeris Medtronic MTS Health Partners Oliver Wyman Penn Biotech Group Welltok